TAS102 Expands Arsenal in Gastric Cancer But Long Road Ahead for Research

TAS-102 Expands Arsenal in Gastric Cancer, But Long Road Ahead for Research

12:12 EDT 24 May 2019 | OncLive

Mark M. Zalupski, MD, sheds light on the current treatment landscape of advanced gastric cancer and the numerous challenges that remain.

More From BioPortfolio on "TAS-102 Expands Arsenal in Gastric Cancer, But Long Road Ahead for Research"